YaltaTYaltaK. Systemic inflammation and arrhythmogenesis: a review of mechanistic and clinical perspectives. Angiology. 2018;69(4):288–296.
2.
ColillaSCrowAPetkunWSingerDESimonTLiuX. Estimates of current and future incidence and prevalence of atrial fibrillation in the U.S. adult population. Am J Cardiol. 2013;112(8):1142–1147.
3.
ButtgereitFDejacoCMattesonELDasguptaB. Polymyalgia rheumatica and giant cell arteritis: a systematic review. JAMA. 2016;315(22):2442–2458.
4.
CoatesLCFitzGeraldOHelliwellPSPaulC. Psoriasis, psoriatic arthritis, and rheumatoid arthritis: is all inflammation the same?Semin Arthritis Rheum. 2016;46(3):291–304.
5.
XuSZWangPGuanSY. Decreased flow-mediated dilatation in patients with rheumatoid arthritis: a meta-analysis. Postgrad Med J. 2017;93(1099):260–265.
6.
TseliosKSheaneBJGladmanDDUrowitzMB. Optimal monitoring for coronary heart disease risk in patients with systemic lupus erythematosus: a systematic review. J Rheumatol. 2016;43(1):54–65.
7.
FilardoSDi PietroMFarcomeniASchiavoniGSessaR. Chlamydia pneumoniae-mediated inflammation in atherosclerosis: a meta-analysis. Mediators Inflamm. 2015;2015:378658.
8.
de OliveiraAPAyoCMBestettiRBBrandao de MattosCCCavasiniCEde MattosLC. The role of CCR5 in Chagas disease—a systematic review. Infect Genet Evol. 2016;45:132–137.
9.
XiaoZPeiZYuanMLiXChenSXuL. Risk of stroke in patients with inflammatory bowel disease: a systematic review and meta-analysis. J Stroke Cerebrovasc Dis. 2015;24(12):2774–2780.
10.
FilimonAMNegreanuLDocaMCiobanuAPredaCMVinereanuD. Cardiovascular involvement in inflammatory bowel disease: dangerous liaisons. World J Gastroenterol. 2015;21(33):9688–9692.
11.
ZhangYSunXIcliBFeinbergMW. Emerging roles for microRNAs in diabetic microvascular disease: novel targets for therapy. Endocr Rev. 2017;38(2):145–168.
12.
SrikanthanKFeyhAVisweshwarHShapiroJISodhiK. Systematic review of metabolic syndrome biomarkers: a panel for early detection, management, and risk stratification in the West Virginian population. Int J Med Sci. 2016;13(1):25–38.
13.
HeLKernogitskiYKulminskayaI. Pleiotropic meta-analyses of longitudinal studies discover novel genetic variants associated with age-related diseases. Front Genet. 2016;7:179.
14.
Ruiz-CanelaMBes-RastrolloMMartinez-GonzalezMA. The role of dietary inflammatory index in cardiovascular disease, metabolic syndrome and mortality. Int J Mol Sci. 2016;17(8):pii: E1265.
15.
SoltaniAChitsaziMJSalehi-AbargoueiA. The effect of dietary approaches to stop hypertension (DASH) on serum inflammatory markers: a systematic review and meta-analysis of randomized trials. Clin Nutr. 2017. doi: 10.1016/j.clnu.2017.02.018
16.
SteffensSWinterCSchlossMJHidalgoAWeberCSoehnleinO. Circadian control of inflammatory processes in atherosclerosis and its complications. Arterioscler Thromb Vasc Biol. 2017;37(6):1022–1028.
17.
MeoSASurayaF. Effect of environmental air pollution on cardiovascular diseases. Eur Rev Med Pharmacol Sci. 2015;19(24):4890–4897.
18.
ParentiAPaccosiSCairoFDefraiaE. Treatment of periodontitis for the prevention of endothelial dysfunction: a narrative review. Curr Vasc Pharmacol. 2015;13(6):749–758.
19.
SanchezPEverettBSalamonsonYAjwaniSGeorgeA. Oral healthcare and cardiovascular disease: a scoping review of current strategies and implications for nurses. J Cardiovasc Nurs. 2017;32(3):E10–E20.
20.
Berlin-BronerYFebbraioMLevinL. Association between apical periodontitis and cardiovascular diseases: a systematic review of the literature. Int Endod J. 2016. doi: 10.1111/iej.12710
21.
GargPChamanC. Apical periodontitis—is it accountable for cardiovascular diseases?J Clin Diagn Res. 2016;10(8):ZE08–ZE12.
22.
AndrawsRBergerJSBrownDL. Effects of antibiotic therapy on outcomes of patients with coronary artery disease: a meta-analysis of randomized controlled trials. JAMA. 2005;293(21):2641–2647.
23.
HammondsTLGathrightECGoldsteinCMPennMSHughesJW. Effects of exercise on C-reactive protein in healthy patients and in patients with heart disease: a meta-analysis. Heart Lung. 2016;45(3):273–282.
24.
FedewaMVHathawayEDWard-RitaccoCL. Effect of exercise training on C reactive protein: a systematic review and meta-analysis of randomised and non-randomised controlled trials. Br J Sports Med. 2017;51(8):670–676.
25.
SuenJThomasJKranzAVunSMillerM. Effect of flavonoids on oxidative stress and inflammation in adults at risk of cardiovascular disease: a systematic review. Healthcare (Basel). 2016;4(3):pii: E69.
26.
JiangJLiKWangF. Effect of marine-derived n-3 polyunsaturated fatty acids on major eicosanoids: a systematic review and meta-analysis from 18 randomized controlled trials. PLoS One. 2016;11(1):e0147351.
27.
SchwingshacklLChristophMHoffmannG. Effects of olive oil on markers of inflammation and endothelial function—a systematic review and meta-analysis. Nutrients. 2015;7(9):7651–7675.
28.
ShahidiFYeoJD. Insoluble-bound phenolics in food. Molecules. 2016;21(9):pii: E1216.
29.
IssacTTDokainishHLakkisNM. Role of inflammation in initiation and perpetuation of atrial fibrillation: a systematic review of the published data. J Am Coll Cardiol. 2007;50(21):2021–2028.
30.
JiangZDaiLSongZLiHShuM. Association between C-reactive protein and atrial fibrillation recurrence after catheter ablation: a meta-analysis. Clin Cardiol. 2013;36(9):548–554.
31.
LiuTLiGLiLKorantzopoulosP. Association between C-reactive protein and recurrence of atrial fibrillation after successful electrical cardioversion: a meta-analysis. J Am Coll Cardiol. 2007;49(15):1642–1648.
32.
WuNXuBXiangY. Association of inflammatory factors with occurrence and recurrence of atrial fibrillation: a meta-analysis. Int J Cardiol. 2013;169(1):62–72.
33.
LiTSunZLXieQY. Meta-analysis identifies serum C-reactive protein as an indicator of atrial fibrillation risk after coronary artery bypass graft. Am J Ther. 2016;23(6):e1586–e1596.
34.
JacobKANathoeHMDielemanJMvan OschDKluinJvan DijkD. Inflammation in new-onset atrial fibrillation after cardiac surgery: a systematic review. Eur J Clin Invest. 2014;44(4):402–428.
35.
KuipersSKlein KlouwenbergPMCremerOL. Incidence, risk factors and outcomes of new-onset atrial fibrillation in patients with sepsis: a systematic review. Crit Care. 2014;18(6):688.
36.
Lee-IannottiJKCapampanganDJHoffman-SnyderC. New-onset atrial fibrillation in severe sepsis and risk of stroke and death: a critically appraised topic. Neurologist. 2012;18(4):239–243.
37.
SwansonDR. Atrial fibrillation in athletes: implicit literature-based connections suggest that overtraining and subsequent inflammation may be a contributory mechanism. Med Hypotheses. 2006;66(6):1085–1092.
38.
YoshidaN. Inflammation and oxidative stress in gastroesophageal reflux disease. J Clin Biochem Nutr. 2007;40(1):13–23.
39.
RomanCBruley des VarannesSMuresanLPicosADumitrascuDL. Atrial fibrillation in patients with gastroesophageal reflux disease: a comprehensive review. World J Gastroenterol. 2014;20(28):9592–9599.
40.
MaharaniNKuwabaraMHisatomeI. Hyperuricemia and atrial fibrillation. Int Heart J. 2016;57(4):395–399.
41.
TamarizLHernandezFBushAPalacioAHareJM. Association between serum uric acid and atrial fibrillation: a systematic review and meta-analysis. Heart Rhythm. 2014;11(7):1102–1108.
42.
RuggieroCCherubiniABleA. Uric acid and inflammatory markers. Eur Heart J. 2006;27(10):1174–1181.
43.
SalihMSmerACharnigoR. Colchicine for prevention of post-cardiac procedure atrial fibrillation: meta-analysis of randomized controlled trials. Int J Cardiol. 2017;243:258–262.
44.
TrivediCSadadiaM. Colchicine in prevention of atrial fibrillation following cardiac surgery: systematic review and meta-analysis. Indian J Pharmacol. 2014;46(6):590–595.
45.
LiuCWangJYiuDLiuK. The efficacy of glucocorticoids for the prevention of atrial fibrillation, or length of intensive care unit or hospital stay after cardiac surgery: a meta-analysis. Cardiovasc Ther. 2014;32(3):89–96.
46.
HoKMTanJA. Benefits and risks of corticosteroid prophylaxis in adult cardiac surgery: a dose-response meta-analysis. Circulation. 2009;119(14):1853–1866.
47.
BakerWLWhiteCMKlugerJDenowitzAKonecnyCPColemanCI. Effect of perioperative corticosteroid use on the incidence of postcardiothoracic surgery atrial fibrillation and length of stay. Heart Rhythm. 2007;4(4):461–468.
48.
MarikPEFrommR. The efficacy and dosage effect of corticosteroids for the prevention of atrial fibrillation after cardiac surgery: a systematic review. J Crit Care. 2009;24(3):458–463.
49.
DielemanJMvan PaassenJvan DijkD. Prophylactic corticosteroids for cardiopulmonary bypass in adults. Cochrane Database Syst Rev. 2011;(5):CD005566.
50.
HadiHAMahmeedWASuwaidiJAEllahhamS. Pleiotropic effects of statins in atrial fibrillation patients: the evidence. Vasc Health Risk Manag. 2009;5(3):533–551.
51.
DentaliFGianniMSquizzatoA. Use of statins and recurrence of atrial fibrillation after catheter ablation or electrical cardioversion. A systematic review and meta-analysis. Thromb Haemost. 2011;106(2):363–370.
52.
BeriASuralNMahajanSB. Non-atheroprotective effects of statins: a systematic review. Am J Cardiovasc Drugs. 2009;9(6):361–370.
53.
Sanchez-QuinonesJMarinFRoldanVLipGY. The impact of statin use on atrial fibrillation. QJM. 2008;101(11):845–861.
54.
PatelAAWhiteCMShahSADaleKMKlugerJColemanCI. The relationship between statin use and atrial fibrillation. Curr Med Res Opin. 2007;23(5):1177–1185.
55.
HowardPABarnesBJ. Potential use of statins to prevent atrial fibrillation after coronary artery bypass surgery. Ann Pharmacother. 2008;42(2):253–258.
56.
LiuTLiLKorantzopoulosPLiuELiG. Statin use and development of atrial fibrillation: a systematic review and meta-analysis of randomized clinical trials and observational studies. Int J Cardiol. 2008;126(2):160–170.
57.
BangCNGreveAMAbdullaJKoberLGislasonGHWachtellK. The preventive effect of statin therapy on new-onset and recurrent atrial fibrillation in patients not undergoing invasive cardiac interventions: a systematic review and meta-analysis. Int J Cardiol. 2013;167(3):624–630.
